Overview
Publication Venue For
Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities.
470:134-140.
2020
The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma.
468:48-58.
2020
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.
459:156-167.
2019
Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel.
454:1-13.
2019
FTY720 enhances the anti-tumor activity of carboplatin and tamoxifen in a patient-derived xenograft model of ovarian cancer.
436:75-86.
2018
Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.
431:1-10.
2018
Retraction notice to “SRI36160 is a specific inhibitor of Wnt/<beta>-catenin signaling in human pancreatic and colorectal cancer cells” [Canc. Lett. 389C (2017) 41–48] (S030438351630800X) (10.1016/j.canlet.2016.12.030)).
422:131.
2018
Prostate cancer health disparities: An immuno-biological perspective.
414:153-165.
2018
Potential therapeutic targets of epithelial–mesenchymal transition in melanoma.
391:125-140.
2017
SRI36160 is a specific inhibitor of Wnt/β-catenin signaling in human pancreatic and colorectal cancer cells.
389:41-48.
2017
Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer.
374:304-314.
2016
Targeting Hsp70: A possible therapy for cancer.
374:156-166.
2016
Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells.
370:91-99.
2016
Targeting drivers of melanoma with synthetic small molecules and phytochemicals.
359:20-35.
2015
Targeted biopharmaceuticals for cancer treatment.
352:145-151.
2014
Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.
349:8-14.
2014
Epigenetic inactivation of DNA repair in breast cancer.
342:213-222.
2014
The mechanistic basis of arsenicosis: Pathogenesis of skin cancer.
354:211-219.
2014
Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway.
348:156-166.
2014
Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling.
353:194-200.
2014
Development of an anti-angiogenic therapeutic model combining scAAV2-delivered siRNAs and noninvasive photoacoustic imaging of tumor vasculature development.
332:120-129.
2013
Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27KIP1 and MMP3 expression.
328:235-242.
2013
A novel mouse model of gastric cancer with human gastric microenvironment.
325:108-115.
2012
Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway.
308:181-188.
2011
Liver Kinase B1 (LKB1) in the pathogenesis of epithelial cancers.
306:1-9.
2011
Bacteriophage hyaluronidase effectively inhibits growth, migration and invasion by disrupting hyaluronan-mediated Erk1/2 activation and RhoA expression in human breast carcinoma cells.
298:238-249.
2010
Lifestyle as risk factor for cancer: Evidence from human studies.
293:133-143.
2010
Molecular mechanisms involved in farnesol-induced apoptosis.
287:123-135.
2010
Serum CXCL13 positively correlates with prostatic disease, prostate-specific antigen and mediates prostate cancer cell invasion, integrin clustering and cell adhesion.
283:29-35.
2009
Expression of the Breast Cancer Metastasis Suppressor 1 (BRMS1) maintains in vitro chemosensitivity of breast cancer cells.
281:100-107.
2009
Targeting transforming growth factor-β signaling in liver metastasis of colon cancer.
277:114-120.
2009
Over-expression of the BRMS1 family member SUDS3 does not suppress metastasis of human cancer cells.
276:32-37.
2009
RAP80 and RNF8, key players in the recruitment of repair proteins to DNA damage sites.
271:179-190.
2008
Dietary agents for chemoprevention of prostate cancer.
265:167-176.
2008
Receptor EphA2 activation with ephrinA1 suppresses growth of malignant mesothelioma (MM).
258:215-222.
2007
Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1).
235:260-265.
2006
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.
202:53-59.
2003
9cUAB30, an RXR specific retinoid, and/or tamoxifen in the prevention of methylnitrosourea-induced mammary cancers.
201:17-24.
2003
Metastasis suppressor pathways - An evolving paradigm.
198:1-20.
2003
Palm oil alleviates 12-O-tetradecanoyl-phorbol-13-acetate-induced tumor promotion response in murine skin.
192:151-160.
2003
Protoporphyrin-IX accumulation and cutaneous tumor regression in mice using a ferrochelatase inhibitor.
187:9-16.
2002
Dietary genistein suppresses chemically induced prostate cancer in Lobund-Wistar rats.
186:11-18.
2002
Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells..
183:215-220.
2002
Iron augments stage-I and stage-II tumor promotion in murine skin.
183:113-122.
2002
Green tea polyphenols and tannic acid act as potent inhibitors of phorbol ester-induced nitric oxide generation in rat hepatocytes independent of their antioxidant properties.
153:1-5.
2000
Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: Implications for carcinogenesis.
141:151-157.
1999
Potassium bromate (KBrO3) induces renal proliferative response and damage by elaborating oxidative stress.
135:181-188.
1999
Augmentation of 12-O-tetradecanoyl 13-phorbol acetate-mediated tumor promoting response by the porphyrin photosensitization of 7,12-dimethyl benz[a]anthracene-initiated murine skin: Role of in situ generated reactive oxygen species.
135:53-60.
1998
Human melanoma metastasis is inhibited following ex vivo treatment with an antisense oligonucleotide to protein kinase C-α.
128:65-70.
1998
Effect of iron overload on the benzoyl peroxide-mediated tumor promotion in mouse skin.
126:135-142.
1998
KAII, a putative marker for metastatic potential in human breast cancer.
119:149-155.
1997
Mutations involving the endogenous ecotropic murine leukemia virus in primary mammary carcinomas of BALB/c mice.
99:121-127.
1996
Development of a novel human extracellular matrix for quantitation of the invasiveness of human cells.
69:123-132.
1993
Involvement of singlet oxygen in chloroaluminum phthalocyanine tetrasulfonate-mediated photoenhancement of lipid peroxidation in rat epidermal microsomes.
56:125-129.
1991
Inhibition of the skin tumorigenicity of (±)-7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene by tannic acid, green tea polyphenols and quercetin in Sencar mice.
42:7-12.
1988
